Abbisko Cayman Limited
HKEX:2256.HK
Overview | Financials
Company Name | Abbisko Cayman Limited |
Symbol | 2256.HK |
Currency | HKD |
Price | 4.7 |
Market Cap | 3,190,908,612 |
Dividend Yield | 0% |
52-week-range | 2.05 - 5.39 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Yao-Chang Xu |
Website | https://www.abbisko.com |
An error occurred while fetching data.
About Abbisko Cayman Limited
Abbisko Cayman Limited, a clinical-stage biopharmaceutical company, discovers and develops small molecule oncology therapies in the People's Republic of China. Its product candidates are primarily small molecules that focus on small molecule precision oncology and small molecule immuno-oncology therapeutic areas. The company's primary product candidates are ABSK011, a small molecule
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD